Sofian M Tijono

Selected publications and creative works (Research Outputs)

  • de Leeuw, M., Henare, K., Ward, C., Tijono, S., Palmer, B., & Ching, L. M. (2/11/2015). Efficacy of a novel IDO1 inhibitor to suppress kynurenine:tryptophan ratios and tumour growth in combination with immune checkpoint blockades. Poster presented at New Zealand Society for Oncology Conference 2015, Christchurch, New Zealand.
    Other University of Auckland co-authors: Kimiora Henare, Brian Palmer, Lai-Ming Ching
  • Ching, L.-M., Henare, K., Tijono, S., & Tomek, P. (2014). The role of two NODs and a STING in the tale of DMXAA. Paper presented at New Zealand Society for Oncology Conference: Oncology in New Zealand; current and future challenges, Tauranga, New Zealand. 21 October - 23 October 2014.
    URL: http://hdl.handle.net/2292/25223
    Other University of Auckland co-authors: Lai-Ming Ching, Kimiora Henare, Petr Tomek
  • Yung, R., Seyfoddin, V., Tijono, S., McGregor, A., & Ching, L. M. (2014). Orthotopic intracranial tumour model in mice for investigating potential therapies for brain cancers. Paper presented at New Zealand Society for Oncology Conference: Oncology in New Zealand; current and future challenges, Tauranga, Auckland. 21 October - 23 October 2014.
    URL: http://hdl.handle.net/2292/25218
    Other University of Auckland co-authors: Lai-Ming Ching
  • Fung, S. P. S., Wang, H., Tomek, P., Squire, C. J., Flanagan, J. U., Palmer, B. D., ... Ching, L. M. (2013). Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1). Bioorganic and Medicinal Chemistry, 21 (24), 7595-7603. 10.1016/j.bmc.2013.10.037
    URL: http://hdl.handle.net/2292/27625
    Other University of Auckland co-authors: Jack Flanagan, Lai-Ming Ching, Brian Palmer, Christopher Squire, Petr Tomek
  • Tijono, S. M., Guo, K., Henare, K., Palmer, B. D., Wang, L.-C. S., Albelda, S. M., & Ching, L.-M. (2013). Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Br J Cancer, 108 (6), 1306-1315. 10.1038/bjc.2013.101
    Other University of Auckland co-authors: Lai-Ming Ching, Brian Palmer, Kimiora Henare
  • Brauer, R., Wang, L. C. S., Woon, S. T., Bridewell, D. J. A., Henare, K., Malinger, D., ... Tijono, S. M. (2010). Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: Evidence for redox signaling in its mode of action. Neoplasia, 12 (9), 755-765. 10.1593/neo.10636
    URL: http://hdl.handle.net/2292/10712
    Other University of Auckland co-authors: Lai-Ming Ching, Brian Palmer, See-Tarn Woon, Kimiora Henare
  • Wang, L.-C. S., Thomsen, L., Sutherland, R., Reddy, C. B., Tijono, S. M., Chen, C.-J. J., ... Ching, L.-M. (2009). Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404). NEOPLASIA, 11 (8), 793-803. 10.1593/neo.09506
    URL: http://hdl.handle.net/2292/11567
    Other University of Auckland co-authors: Chun-Jen Jennifer Chen, Catherine Angel, Rod Dunbar, Lai-Ming Ching
  • Ching, L., Tijono, S. M., Wang, S., & Bai Reddy, C. (4/9/2008). Use of multiplex cytokine screens to determine potential surrogate markers of response to the anti-cancer drug DMXAA. Poster presented at Queenstown Molecular Biology Meeting, Queenstown, N.Z..
    Other University of Auckland co-authors: Lai-Ming Ching

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 005
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand